Vascular Access Devices

2011 ◽  
pp. 166-173
2021 ◽  
pp. 112972982110414
Author(s):  
Jennifer Clesham ◽  
Helen Reynolds ◽  
Peter J Carr

Introduction: The extent of vascular/venous access device (VAD) research output from the Island of Ireland is unknown. The identification of the papers available is important to create a future research agenda. Objectives: The main objective of this study is to answer three questions: What is the number and descriptive quality of reported Vascular Access Device literature from the Island of Ireland? Is the reporting of Catheter Related Infection rates for cancer patients common in Irish Hospital Groups, National Cancer Reports and Publication Outputs? What are the implications for future research in this area? Methods: We used a scoping review and searched selected databases, grey literature and hospital regulatory bodies websites following the Joanna Briggs Institute Guidelines 2017. A data charting form was developed based on a template from the Joanna Briggs Institute and this was used to extract data from the included reports. Results: A total of 660 reports were screened. Sixty-one full text articles were reviewed from which 20 reports were included for data extraction. Of the reports included the following designs were used: nine retrospective study designs, four guidelines, two prospective study designs, two literature reviews and one of the following; survey, case study and cross sectional analysis designs. We did not identify any randomised controlled trials, systematic reviews, meta-analysis, meta-synthesis and scoping reviews. Five studies included catheter related infection rates. Gaps in the research include the collection of data sets and the need to establish a VAD registry; develop core outcomes for VADs; assessment and evaluation of VAD care bundles among cancer patients; and, the inclusion of public and patient involvement in future VAD research. Conclusion: The reporting of VAD outcomes in published literature regarding cancer patients receiving treatment in Ireland is inconsistent and varied with no interventional studies addressing vascular access complications in cancer care.


2018 ◽  
Vol 172 ◽  
pp. 54-60 ◽  
Author(s):  
Darren White ◽  
Scott C. Woller ◽  
Scott M. Stevens ◽  
Dave S. Collingridge ◽  
Vineet Chopra ◽  
...  

2019 ◽  
Vol 91 ◽  
pp. 6-13 ◽  
Author(s):  
Amanda J. Ullman ◽  
Gabor Mihala ◽  
Kate O’Leary ◽  
Nicole Marsh ◽  
Christine Woods ◽  
...  

2004 ◽  
Vol 9 (1) ◽  
pp. 41-43
Author(s):  
Cynthia Chernecky ◽  
Katherine Nugent ◽  
Jennifer L. Waller ◽  
Denise Macklin

Abstract The purposes of this study were to describe who should be involved in the vascular access device (VAD) decision-making process, according to patients and caregivers, and to describe if there were differences associated with persons involved in the selection of VADs according to race and gender. Convenience sample included 32 oncology out-patients and 10 caregivers from the southern United States. There were differences by race and sex in decision-making priorities of patients with vascular access devices indwelling; however, these were not statistically significant. Patients, physicians, and oncology nurses were viewed by both patients and caregivers as significant to the decision-making process. In contrast, caregivers were ranked as the least significant by both patients and caregivers. Females chose the physician as the primary decision-maker while males chose the patient as the primary decision-maker.


Author(s):  
Saraswathi Murthy ◽  
Susan Hopkins

Approximately 400 000 adults (>600 per 100 000) living in the United Kingdom are affected by rheumatological diseases and infection is a common cause of morbidity and mortality in these individuals. This chapter provides an overview of the factors that potentiate infection risk within rheumatological diseases related to the diseases themselves and the treatment of the diseases. It reviews the common infections encountered and their aetiologies and management. Importantly it also focuses on preventable measures that should be undertaken, such as care of vascular access devices, vaccinations, immunizations, and prophylactic antimicrobials.


2020 ◽  
Vol 29 (8) ◽  
pp. S28-S33
Author(s):  
Andrew Barton

The use of sutureless, adhesive securement devices in vascular access has become recommended as best practice, because they are a cost-effective, reliable solution. After a vascular access device has been inserted, catheter securement is one of the most important aspects of care and maintenance. The Grip-Lok® range offers secure, comfortable adhesive securement for all types of vascular access devices. The products use hypoallergenic medical adhesive, which reduces the risk of skin irritation and provides a reliable, adaptable alternative to suturing.


Sign in / Sign up

Export Citation Format

Share Document